ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,967.23
      -0.88%
      US Tech 100
      16,579.62
      -2.11%
      Dow Jones
      37,986.40
      0.56%
      Brent Oil
      86.625
      0.24%
      Bitcoin
      64,164.89
      1.03%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Femasys Inc (FEMY)

      7. Femasys Inc (FEMY) News

      FEMY

      Femasys (FEMY)

      Femasys Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FEMY
      DateTimeSourceHeadlineSymbolCompany
      04/18/20248:30AMGlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesNASDAQ:FEMYFemasys Inc
      03/28/20244:05PMGlobeNewswire Inc.Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
      03/21/20249:00AMGlobeNewswire Inc.Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment LandscapeNASDAQ:FEMYFemasys Inc
      03/20/20248:15AMGlobeNewswire Inc.Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of InfertilityNASDAQ:FEMYFemasys Inc
      03/13/20249:00AMGlobeNewswire Inc.Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024NASDAQ:FEMYFemasys Inc
      03/06/20249:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
      03/06/20249:00AMGlobeNewswire Inc.Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility SolutionNASDAQ:FEMYFemasys Inc
      02/28/20249:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
      02/13/20249:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
      02/13/20249:44PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
      02/06/20248:47AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
      02/02/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
      02/02/20244:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
      02/02/20244:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
      12/11/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FEMYFemasys Inc
      12/08/20239:28AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
      11/30/20235:17PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FEMYFemasys Inc
      11/29/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
      11/22/20234:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
      11/22/20234:33PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
      11/22/20234:12PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FEMYFemasys Inc
      11/21/20235:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
      11/15/20235:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
      11/15/20238:30AMBusiness WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:FEMYFemasys Inc
      11/01/20239:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
      10/11/20238:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
      10/03/20239:28AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
      10/03/20239:27AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
      09/27/20238:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
      09/06/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
       Showing the most relevant articles for your search:NASDAQ:FEMY